MedSuite

Cancer Antigen 19-9 (CA 19-9)

Oncology

Normal Reference Ranges

Adult

< 37 U/mL

Pediatric

N/A U/mL

Clinical Significance

Tumor marker primarily used to monitor response to therapy and detect recurrence in patients with pancreatic cancer.

Causes of High

  • Pancreatic adenocarcinoma
  • Cholangiocarcinoma
  • Colorectal, gastric, or ovarian cancers
  • Biliary obstruction / cholangitis
  • Cirrhosis

Causes of Low

  • Lewis antigen-negative individuals (approx 5-10% of population fail to synthesize CA 19-9)